Johnson & Johnson dumped Aegis Group’s Carat as it began a root-and-branch review of its media planning and buying assignments, according to Advertising Age. Carat had handled media on a number of the Pfizer OTC brands being acquired by J&J. Those brands will be divided up among roster agencies that survive the review, Ad Age reported.